Jazz Pharmaceuticals
JAZZ
JAZZ
467 hedge funds and large institutions have $7.75B invested in Jazz Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 157 increasing their positions, 147 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 467 → 467 (0)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
13% less capital invested
Capital invested by funds: $8.87B → $7.75B (-$1.13B)
Holders
467
Holding in Top 10
9
Calls
$65.9M
Puts
$36.3M
Top Buyers
| 1 | +$179M | |
| 2 | +$66.2M | |
| 3 | +$48.1M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$40.4M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$34.2M |
Top Sellers
| 1 | -$110M | |
| 2 | -$81.4M | |
| 3 | -$52.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$51M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$44.3M |